Provectus Biopharmaceuticals, Inc.
OTC:PVCT
0.1491 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.558 | 0.989 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.178 | 0 | 0 | 9,759.969 | 0 | 0 | 0 | 0 | 0.001 | 0.007 | 0.032 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.699 | 0.064 | 0.094 | 0.315 | 0.756 | 0.685 | 13.721 | 24.512 | 24.654 | 12,633.028 | 13,027.939 | 14,337.619 | 0 | 20.693 | 12.326 | 0 | 10.312 | 0.001 | 0.004 | 0.011 | 0 | 0 | 0 | 0 |
| Gross Profit
| -1.142 | 0.925 | -0.094 | -0.315 | -0.756 | -0.685 | -13.721 | -24.512 | -24.654 | -12,628.85 | -13,027.939 | -14,337.619 | 9,759.969 | -20.693 | -12.326 | 0 | -10.312 | 0 | 0.003 | 0.021 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| -2.047 | 0.936 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3,022.453 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0.36 | 0.455 | 0.662 | 0 | 0 | 0 | 1 |
| Reseach & Development Expenses
| 1.749 | 2.389 | 2.608 | 2.813 | 4.002 | 4.748 | 8.204 | 8.543 | 10.709 | 5.138 | 3.596 | 5.005 | 8.808 | 8.417 | 4.909 | 4.426 | 4.405 | 3.016 | 2.044 | 1.292 | 0.725 | 0.051 | 0 | 0 |
| General & Administrative Expenses
| 1.305 | 2.025 | 2.055 | 2.145 | 2.298 | 3.307 | 5.518 | 15.969 | 13.274 | 11.002 | 8.761 | 8.661 | 0 | 11.605 | 6.746 | 5.247 | 5.236 | 3.535 | 2.999 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0.051 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1.357 | 2.025 | 2.055 | 2.145 | 2.298 | 3.307 | 5.518 | 15.969 | 13.274 | 11.002 | 8.761 | 8.661 | 11.962 | 11.605 | 6.746 | 5.247 | 5.236 | 3.535 | 2.999 | 1.691 | 1.582 | 6.923 | 0.13 | 0.012 |
| Other Expenses
| -1.346 | -1.023 | -0.027 | -0.026 | -0.134 | -0.026 | 0 | 0 | 0.671 | 0.671 | 0.671 | 0.671 | 0.671 | 0.671 | 0.671 | 0.671 | 0.671 | 0.671 | 0.671 | 0.671 | 1.148 | 0.134 | 0 | 0 |
| Operating Expenses
| 1.76 | 3.391 | 4.636 | 4.932 | 6.166 | 8.028 | 13.721 | 24.512 | 24.654 | 16.811 | 13.028 | 14.338 | 21.441 | 20.693 | 12.326 | 10.344 | 10.312 | 7.222 | 5.715 | 3.654 | 3.455 | 7.108 | 0.13 | 0.012 |
| Operating Income
| -2.901 | -3.428 | -4.672 | -4.964 | -6.3 | -8.008 | -13.721 | -24.512 | -24.654 | -12.633 | -13.028 | -14.338 | -21.441 | -20.693 | -12.326 | -10.344 | -10.312 | -7.222 | -5.712 | -3.633 | -3.455 | -7.108 | -0.13 | -0.011 |
| Operating Income Ratio
| -5.202 | -3.466 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.023 | 0 | 0 | -0.002 | 0 | 0 | 0 | 0 | -5,278.936 | -873.909 | -114.046 | 0 | 0 | 0 | -11,499 |
| Total Other Income Expenses Net
| -0.201 | -0.127 | -0.867 | -1.714 | -0.623 | 0.825 | 0.204 | 0.085 | 0.151 | 2.39 | -14.67 | 1.768 | 2.006 | 2.141 | 0.004 | 0.074 | 0.318 | 0.253 | -0.724 | -0.101 | 0.055 | 0 | 0 | 0 |
| Income Before Tax
| -3.102 | -3.555 | -5.54 | -6.678 | -6.923 | -8.153 | -13.518 | -24.427 | -24.502 | -10.243 | -27.698 | -12.568 | -19.435 | -18.552 | -12.322 | -10.27 | -9.994 | -6.968 | -6.436 | -3.734 | -3.4 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -5.562 | -3.594 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.451 | 0 | 0 | -0.002 | 0 | 0 | 0 | 0 | -5,093.653 | -984.75 | -117.23 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.016 | -0 | 0.962 | 1.748 | 1.455 | -0.825 | -0.407 | -0.17 | -0.303 | -4.78 | 29.34 | -3.539 | -4.012 | -4.282 | -0.008 | -0.148 | -0.624 | 1.396 | 6.776 | 0.813 | 0.122 | 0.014 | 0.13 | 0 |
| Net Income
| -3.102 | -3.554 | -6.501 | -8.426 | -8.378 | -8.153 | -13.518 | -24.427 | -24.502 | -10.243 | -27.698 | -12.568 | -19.435 | -18.552 | -12.322 | -10.27 | -10.006 | -8.871 | -11.764 | -4.345 | -3.632 | -7.122 | -0.13 | -0.012 |
| Net Income Ratio
| -5.562 | -3.594 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.451 | 0 | 0 | -0.002 | 0 | 0 | 0 | 0 | -6,484.341 | -1,799.855 | -136.393 | 0 | 0 | 0 | -11,500 |
| EPS
| -0.007 | -0.009 | -0.016 | -0.021 | -0.022 | -0.021 | -0.037 | -0.1 | -0.13 | -0.058 | -0.21 | -0.11 | -0.18 | -0.24 | -0.21 | -0.2 | -0.22 | -0.23 | -0.62 | -0.31 | -0.37 | -0.89 | -1.52 | -0.035 |
| EPS Diluted
| -0.007 | -0.009 | -0.016 | -0.021 | -0.022 | -0.021 | -0.037 | -0.1 | -0.13 | -0.058 | -0.21 | -0.11 | -0.18 | -0.24 | -0.21 | -0.2 | -0.22 | -0.23 | -0.62 | -0.31 | -0.37 | -0.89 | -1.52 | -0.035 |
| EBITDA
| -2.489 | -3.381 | -4.623 | -4.686 | -5.457 | -7.323 | -13.238 | -23.913 | -24.121 | -14.343 | 2.319 | -15.428 | -22.769 | -22.154 | -11.649 | -9.737 | -9.859 | -4.948 | -0.062 | -1.612 | -1.994 | -6.928 | -0.13 | -0.011 |
| EBITDA Ratio
| -4.464 | -3.418 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.433 | 0 | 0 | -0.002 | 0 | 0 | 0 | 0 | -3,616.955 | -9.561 | -50.593 | 0 | 0 | 0 | -11,499 |